The global veterinary anti-infective market has established a strong position in 2024, with estimated revenue of USD 5.03 billion. This reflects expanding demand for treatments to prevent and control infectious diseases in both livestock and companion animals. Growing concerns over foodborne and zoonotic diseases, increasing pet ownership, and higher investments in animal health infrastructure...